Filtration markers in acute kidney injury

American Journal of Kidney Diseases

Volumn 56, Issue 4, 2010, Pages 619-622

  Levey, Andrew S ^a   Deo, Aneet ^a   Jaber, Bertrand L ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BICARBONATE; BIOLOGICAL MARKER; CISPLATIN; CONTRAST MEDIUM; CREATININE; CYSTATIN C;

CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY ANGIOGRAPHY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; MORTALITY; NONHUMAN; NOTE; PHYSICIAN; PROGNOSIS; PROTEIN URINE LEVEL; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 77956916365     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.08.001     Document Type: Editorial

References (30)

1. S.G. Coca, B. Yusuf, M.G. Shlipak, A.X. Garg, and C.R. Parikh Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis Am J Kidney Dis 53 6 2009 961 973
2. R. Bellomo, C. Ronco, J.A. Kellum, R.L. Mehta, and P. Palevsky Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group Crit Care 8 4 2004 R204 R212
3. R.L. Mehta, J.A. Kellum, and S.V. Shah Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury Crit Care 11 2 2007 R31
4. C. Briguori, G. Visconti, and N.V. Rivera Cystatin C and contrast-induced acute kidney injury Circulation 121 19 2010 2117 2122
5. S.G. Coca, R. Yalavarthy, J. Concato, and C.R. Parikh Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review Kidney Int 73 9 2008 1008 1016
6. L.A. Stevens, and A.S. Levey Measured GFR as a confirmatory test for estimated GFR J Am Soc Nephrol 20 11 2009 2305 2313
7. L.A. Stevens, C.H. Schmid, and T. Greene Factors other than glomerular filtration rate affect serum cystatin C levels Kidney Int 75 6 2009 652 660
8. M. Fricker, P. Wiesli, M. Brndle, B. Schwegler, and C. Schmid Impact of thyroid dysfunction on serum cystatin C Kidney Int 63 5 2003 1944 1947
9. M.C. Perianayagam, V.F. Seabra, H. Tighiouart, O. Liangos, and B.L. Jaber Serum cystatin C for prediction of dialysis requirement or death in acute kidney injury: a comparative study Am J Kidney Dis 54 6 2009 1025 1033
10. S.S. Waikar, and J.V. Bonventre Creatinine kinetics and the definition of acute kidney injury J Am Soc Nephrol 20 3 2009 672 679
11. K. Doi, P.S. Yuen, and C. Eisner Reduced production of creatinine limits its use as marker of kidney injury in sepsis J Am Soc Nephrol 20 6 2009 1217 1221
12. P. Sjstrm, M. Tidman, and I. Jones The shorter t1/2 of cystatin C explains the earlier change of its serum level compared to serum creatinine Clin Nephrol 62 3 2004 241 242
13. O. Tenstad, A.B. Roald, A. Grubb, and K. Aukland Renal handling of radiolabelled human cystatin C in the rat Scand J of Clin Lab Invest 56 5 1996 409 414
14. Y. Abu-Omar, S. Mussa, M.J. Naik, N. MacCarthy, S. Standing, and D.P. Taggart Evaluation of cystatin C as a marker of renal injury following on-pump and off-pump coronary surgery Eur J Cardiothorac Surg 27 5 2005 893 898
15. G. Biancofiore, L. Pucci, and E. Cerutti Cystatin C as a marker of renal function immediately after liver transplantation Liver Transpl 12 2 2006 285 291
16. B. Stabuc, L. Vrhovec, M. Stabuc-Silih, and T.E. Cizej Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy Clin Chem 46 2 2000 193 197
17. P. Benhr, A. Grenz, J.T. Hartmann, G.A. Mller, and S. Blaschke Cystatin C - a marker for assessment of the glomerular filtration rate in patients with cisplatin chemotherapy Kidney Blood Press Res 29 1 2006 32 35
18. J. Zhu, R. Yin, and H. Wu Cystatin C as a reliable marker of renal function following heart valve replacement surgery with cardiopulmonary bypass Clin Chim Acta 374 1-2 2006 116 121
19. P. Villa, M. Jimnez, M.C. Soriano, J. Manzanares, and P. Casasnovas Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients Crit Care 9 2 2005 R139 R143
20. S. Herget-Rosenthal, G. Marggraf, and J. Hsing Early detection of acute renal failure by serum cystatin C Kidney Int 66 3 2004 1115 1122
21. A. Ahlstrm, M. Tallgren, S. Peltonen, and V. Pettil Evolution and predictive power of serum cystatin C in acute renal failure Clin Nephrol 62 5 2004 344 350
22. J.L. Koyner, M.R. Bennett, and E.M. Worcester Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery Kidney Int 74 8 2008 1059 1069
23. Wald R, Liangos O, Perianayagam MC, et al. Plasma cystatin C and acute kidney injury after cardiopulmonary bypass [published online ahead of print June 3, 2010]. Clin J Am Soc Nephrol. doi:10.2215/CJN.06350909.
24. A. Haase-Fielitz, R. Bellomo, and P. Devarajan Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery - a prospective cohort study Crit Care Med 37 2 2009 553 560
25. Krawczeski CD, Vandevoorde RG, Kathman T, et al. Serum cystatin C is an early predictive biomarker of acute kidney injury after pediatric cardiopulmonary bypass [published online ahead of print June 10, 2010]. Clin J Am Soc Nephrol. doi:10.2215/CJN.02040310.
26. M. Bell, F. Granath, J. Mrtensson, E. Lfberg, A. Ekbom, C.R. Martling KING (Karolinska Intensive care Nephrology Group) Cystatin C is correlated with mortality in patients with and without acute kidney injury Nephrol Dial Transplant 24 10 2009 3096 3102
27. A. Ristikankare, R. Pyhi, and A. Kuitunen Serum cystatin C in elderly cardiac surgery patients Ann Thorac Surg 89 3 2010 689 694
28. C.A. White, A. Akbari, and S. Doucette Effect of clinical variables and immunosuppression on serum cystatin C and beta-trace protein in kidney transplant recipients Am J Kidney Dis 54 5 2009 922 930
29. R. Jelliffe Estimation of creatinine clearance in patients with unstable renal function, without a urine specimen Am J Nephrol 22 4 2002 320 324
30. J.P. Kassirer Clinical evaluation of kidney function - glomerular function N Engl J Med 285 7 1971 385 389